Raising Standards in Ketamine Care

Ketamine-assisted care is gaining attention because it can offer meaningful relief for people when conventional approaches fall short. As access expands, however, so does confusion. Patients encounter conflicting information, inconsistent protocols, and widely varying levels of clinical oversight. I’ve seen how disorienting it can be for patients to navigate ketamine care without clear guidance, which is why my focus has always been on responsibility, alignment, and measurable care rather than access alone.

Clarity Comes First

One of the most common challenges in ketamine care today is a lack of clarity around how different treatment models actually differ. IV ketamine, esketamine, and oral formulations are often discussed interchangeably, despite meaningful differences in dosing precision, monitoring, and overall clinical control. Public conversation can further blur these distinctions, sometimes framing ketamine as either a quick fix or a non-clinical experience, which ultimately undermines patient trust.

Addressing this starts with education. Patients deserve a clear understanding of what ketamine is, how it works, and what responsible treatment entails. I also emphasize preparation and integration alongside the medication itself. Ketamine may create a window for change, but how patients engage before and after sessions strongly influences whether benefits are short-lived or sustained.

Care Coordination and Clinical Clearance

Ketamine therapy is most effective when it’s introduced within a clear clinical structure that supports safety, continuity, and accountability. When a patient already has an established provider, we keep that provider at the center of the patient’s ongoing care and coordinate closely to maintain alignment on diagnosis, medications, and treatment goals.

When that structure does not already exist, our responsibility is to establish it before treatment begins. That includes a complete psychiatric assessment to confirm the patient has appropriate mental health clearance, no contraindications to treatment, and that ketamine is clinically appropriate at this point in their care.

Just as importantly, we want to ensure we’re treating the right candidate and that we can deliver meaningful, measurable outcomes safely. We track outcomes throughout treatment and communicate updates back to the referring provider to support continuity and long-term success.

Safety and Measurement Matter

A structured, physician-led model is essential to maintaining consistency and clinical responsibility. Before treatment begins, patients undergo a medical evaluation to ensure they are physically appropriate for IV ketamine, alongside psychiatric screening to assess overall clinical fit. With IV ketamine in particular, precise dosing and continuous monitoring allow care teams to manage physiologic effects in real time and respond appropriately during each session. Post-session assessment then helps determine both safety and response before moving forward.

Measurement is the other pillar that cannot be overlooked. Tracking progress with validated tools such as the PHQ-9 and GAD-7 before, during, and after treatment provides an objective view of change. This data informs clinical decisions, supports appropriate adjustments, and allows care teams to communicate clearly about what is changing and what still needs attention.

What Patients Should Ask

Two things come up often when people start looking into ketamine therapy. The first is the idea that ketamine is either a “quick fix” or it won’t work at all. In reality, some patients do feel relief quickly, sometimes even after the first few sessions. More importantly, long-term progress is absolutely possible when treatment is delivered within the right clinical structure and supported by what happens outside the infusion. Therapy, preparation, reflection, and consistent lifestyle support during periods of increased neuroplasticity can turn early relief into durable change.

The second is the idea that all ketamine options are equivalent. They aren’t. Differences in administration, dosing consistency, medical monitoring, and clinical follow-up can meaningfully affect safety and outcomes. Patients should feel comfortable asking who is medically responsible for their care across the protocol, what monitoring is used during sessions, and how progress is evaluated over time.

Ultimately, ketamine care works best when it is coordinated rather than fragmented. A collaborative approach that keeps a patient’s existing psychiatrist, therapist, or prescriber in the loop helps create continuity and accountability throughout the process. Clear clinical ownership, physician oversight, structured support, and measurable outcomes are what make this treatment consistent, safe, and worth pursuing. As the field grows, the clinics that matter won’t be the ones offering the most. They’ll be the ones delivering the safest care, the most consistent protocols, and the strongest outcomes.